Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Chronic Pain Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Chronic Pain Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Drugs
      • 1.3.3 Devices
    • 1.4 Market Segment by Application
      • 1.4.1 Global Chronic Pain Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Nursing Homes
      • 1.4.5 Research Centers & Universities
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Chronic Pain Treatment Market Size
      • 2.1.1 Global Chronic Pain Treatment Revenue 2014-2025
      • 2.1.2 Global Chronic Pain Treatment Sales 2014-2025
    • 2.2 Chronic Pain Treatment Growth Rate by Regions
      • 2.2.1 Global Chronic Pain Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Chronic Pain Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Chronic Pain Treatment Sales by Manufacturers
      • 3.1.1 Chronic Pain Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Chronic Pain Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Chronic Pain Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Chronic Pain Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Chronic Pain Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Chronic Pain Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Chronic Pain Treatment Market
    • 3.6 Key Manufacturers Chronic Pain Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Drugs Sales and Revenue (2014-2019)
      • 4.1.2 Devices Sales and Revenue (2014-2019)
    • 4.2 Global Chronic Pain Treatment Sales Market Share by Type
    • 4.3 Global Chronic Pain Treatment Revenue Market Share by Type
    • 4.4 Chronic Pain Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Chronic Pain Treatment Sales by Application

    6 United States

    • 6.1 United States Chronic Pain Treatment Breakdown Data by Company
    • 6.2 United States Chronic Pain Treatment Breakdown Data by Type
    • 6.3 United States Chronic Pain Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Chronic Pain Treatment Breakdown Data by Company
    • 7.2 European Union Chronic Pain Treatment Breakdown Data by Type
    • 7.3 European Union Chronic Pain Treatment Breakdown Data by Application

    8 China

    • 8.1 China Chronic Pain Treatment Breakdown Data by Company
    • 8.2 China Chronic Pain Treatment Breakdown Data by Type
    • 8.3 China Chronic Pain Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Chronic Pain Treatment Breakdown Data by Company
    • 9.2 Rest of World Chronic Pain Treatment Breakdown Data by Type
    • 9.3 Rest of World Chronic Pain Treatment Breakdown Data by Application
    • 9.4 Rest of World Chronic Pain Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Chronic Pain Treatment Sales by Countries
      • 9.4.2 Rest of World Chronic Pain Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Eli Lilly and Company
      • 10.1.1 Eli Lilly and Company Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.1.4 Chronic Pain Treatment Product Introduction
      • 10.1.5 Eli Lilly and Company Recent Development
    • 10.2 GlaxoSmithKline
      • 10.2.1 GlaxoSmithKline Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.2.4 Chronic Pain Treatment Product Introduction
      • 10.2.5 GlaxoSmithKline Recent Development
    • 10.3 Pfizer
      • 10.3.1 Pfizer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.3.4 Chronic Pain Treatment Product Introduction
      • 10.3.5 Pfizer Recent Development
    • 10.4 Medtronic
      • 10.4.1 Medtronic Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.4.4 Chronic Pain Treatment Product Introduction
      • 10.4.5 Medtronic Recent Development
    • 10.5 Abbott Laboratories
      • 10.5.1 Abbott Laboratories Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.5.4 Chronic Pain Treatment Product Introduction
      • 10.5.5 Abbott Laboratories Recent Development
    • 10.6 Boston Scientific Corporation
      • 10.6.1 Boston Scientific Corporation Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.6.4 Chronic Pain Treatment Product Introduction
      • 10.6.5 Boston Scientific Corporation Recent Development
    • 10.7 Novartis AG
      • 10.7.1 Novartis AG Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.7.4 Chronic Pain Treatment Product Introduction
      • 10.7.5 Novartis AG Recent Development
    • 10.8 Johnson & Johnson
      • 10.8.1 Johnson & Johnson Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.8.4 Chronic Pain Treatment Product Introduction
      • 10.8.5 Johnson & Johnson Recent Development
    • 10.9 AstraZeneca PLC
      • 10.9.1 AstraZeneca PLC Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.9.4 Chronic Pain Treatment Product Introduction
      • 10.9.5 AstraZeneca PLC Recent Development
    • 10.10 Bristol-Myers Squibb
      • 10.10.1 Bristol-Myers Squibb Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Chronic Pain Treatment
      • 10.10.4 Chronic Pain Treatment Product Introduction
      • 10.10.5 Bristol-Myers Squibb Recent Development
    • 10.11 Becton, Dickinson and Company
    • 10.12 Sanofi

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Chronic Pain Treatment Sales Channels
      • 11.2.2 Chronic Pain Treatment Distributors
    • 11.3 Chronic Pain Treatment Customers

    12 Market Forecast

    • 12.1 Global Chronic Pain Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Chronic Pain Treatment Sales Forecast by Type
    • 12.3 Global Chronic Pain Treatment Sales Forecast by Application
    • 12.4 Chronic Pain Treatment Forecast by Regions
      • 12.4.1 Global Chronic Pain Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Chronic Pain Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      This report mainly studies Chronic Pain Treatment market. The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.
      During the forecast period, the chronic pain treatment market is expected to witness the fastest growth in the APAC region.
      In 2019, the market size of Chronic Pain Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Chronic Pain Treatment.

      This report studies the global market size of Chronic Pain Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Chronic Pain Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Eli Lilly and Company
      GlaxoSmithKline
      Pfizer
      Medtronic
      Abbott Laboratories
      Boston Scientific Corporation
      Novartis AG
      Johnson & Johnson
      AstraZeneca PLC
      Bristol-Myers Squibb
      Becton, Dickinson and Company
      Sanofi

      Market Segment by Product Type
      Drugs
      Devices

      Market Segment by Application
      Hospitals
      Clinics
      Nursing Homes
      Research Centers & Universities

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Chronic Pain Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Chronic Pain Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Chronic Pain Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now